Cargando…

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

BACKGROUND: Morbidity in COPD results from a combination of factors including hypoxia-induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal studies suggest a role of angiotensin II and acute studies in man concur. Whether chronic angiotensin-II blockade is beneficial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrell, Nicholas W, Higham, Matthew A, Phillips, Peter G, Shakur, B Haleema, Robinson, Paul J, Beddoes, Ray J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1198258/ https://www.ncbi.nlm.nih.gov/pubmed/16060962 http://dx.doi.org/10.1186/1465-9921-6-88

Ejemplares similares

The role of the liver X receptor in chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2013)

Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
por: Aurangabadkar, Gaurang M, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease and COVID-19: interrelationships
por: Singh, Dave, et al.
Publicado: (2022)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
por: Li, Mengxi
Publicado: (2023)

Study of Pulmonary Hypertension in Patients Suffering from Chronic Obstructive Pulmonary Disease
por: TUDORAȘCU, D.R., et al.
Publicado: (2016)

Care of the Surgical ICU Patient with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
por: Kassutto, Stacey M., et al.
Publicado: (2016)

The role of genomics and genetics in pulmonary arterial hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2020)

Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2022)

Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: Possible involvement of angiotensin-converting enzyme-2
por: Han, Su-Xia, et al.
Publicado: (2010)

Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2020)

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)

Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease
por: Fujii, Hiroyuki, et al.
Publicado: (2023)

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Patients With Chronic Obstructive Pulmonary Disease: A Note of Caution
por: Cheng, Richard, et al.
Publicado: (2023)

Use of Tadalafil for Treating Pulmonary Arterial Hypertension Secondary to Chronic Obstructive Pulmonary Disease
por: Kim, Hyun-Sook, et al.
Publicado: (2007)

The use of iloprost in the treatment of ‘out of proportion’ pulmonary hypertension in chronic obstructive pulmonary disease
por: Lasota, Bartosz, et al.
Publicado: (2013)

The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
por: Bajwa, Abubakr A., et al.
Publicado: (2017)

A Nomogram for Predicting the Risk of Pulmonary Hypertension for Patients with Chronic Obstructive Pulmonary Disease
por: Wang, Ning, et al.
Publicado: (2022)

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes
por: Wang, Lixia, et al.
Publicado: (2023)

Value of the neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease complicated with pulmonary hypertension
por: Jiang, Tingting, et al.
Publicado: (2023)

Genetics of pulmonary arterial hypertension: do the molecular findings have translational value?
por: Morrell, Nicholas W
Publicado: (2010)

Quantitative Computed Tomography of Pulmonary Emphysema and Ventricular Function in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension
por: Huang, Yu-Sen, et al.
Publicado: (2014)

Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life
por: Gupta, Kamlesh Kumar, et al.
Publicado: (2018)

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial
por: Maron, Bradley A., et al.
Publicado: (2022)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
por: Parmaksız, Elif Torun, et al.
Publicado: (2018)

Role of Selexipag in Chronic Obstructive Pulmonary Disease (COPD) Patients With Out-of-Proportion Pulmonary Hypertension
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Correction: Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes
por: Wang, Lixia, et al.
Publicado: (2023)

Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2021)

Chronic obstructive pulmonary disease
por: Madison, J Mark, et al.
Publicado: (1998)

T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
por: Kaur, Manminder, et al.
Publicado: (2012)

Pulmonary embolism with chronic obstructive pulmonary disease
por: Yang, Ruohan, et al.
Publicado: (2021)

Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease
por: Chandy, Dipak, et al.
Publicado: (2013)

Chronic thromboembolic pulmonary hypertension
por: Schölzel, B. E., et al.
Publicado: (2014)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Genetics and genomics of pulmonary arterial hypertension
por: Morrell, Nicholas W., et al.
Publicado: (2019)

Early-onset, Severe Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension that was Likely Induced by Toluene Exposure
por: Kobayashi, Konomi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_772tc70qju68nhbo0l6h2u9381